Drug · DIN 02483076
UNITUXIN
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 1, 2019; first marketed May 1, 2019.
- Drug Identification Number (DIN)
- 02483076
- Company (DIN owner)
- United Therapeutics CorporationDurham, North Carolina, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Dinutuximab beta L01FX06
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DINUTUXIMAB | 3.5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 28, 2018: NOC 21570New Drug Submission (NDS)